Media release
From:
Vaccine escape in a heterogeneous population: insights for SARS-CoV-2 from a simple model
Royal Society Open Science
The rapid development and deployment of vaccines is the success story of the COVID-19 pandemic. However this comes with the risk of vaccine escape: the possibility that SARS-CoV-2 can mutate to produce a variant to which the vaccines are less effective.
The modelling work in this paper shows that the highest risk for vaccine escape will be at intermediate levels of vaccination, and in particular when the most vulnerable are vaccinated but not the rest of the population. Careful targeting of vaccines towards particular population groups could reduce disease as much as possible whilst limiting the risk of vaccine escape.